Benjamin Kornitzer - 18 Apr 2022 Form 4/A - Amendment Insider Report for agilon health, inc. (AGL)

Role: Chief Med. & Quality Officer
Signature: /s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol: AGL
Transactions as of: 18 Apr 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 29 Apr 2022, 18:01:10 UTC
Date Of Original Report: 20 Apr 2022
Previous filing: 29 Sep 2022
Next filing: 29 Apr 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGL	Options (Rights to Buy)	Options Exercise	$0	-6,477	-1.2%	$0.000000	532,048	18 Apr 2022	Common Stock	6,477	$4.49	Direct	F1
transaction	AGL	Options (Rights to Buy)	Options Exercise	$0	-6,296	-1.2%	$0.000000	525,752	19 Apr 2022	Common Stock	6,296	$4.49	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024.

Remarks:

This Form 4 Amendment corrects the total number of options in this grant beneficially owned by the Reporting Filer, which was inadvertently misstated on the Form 4 filed on April 20, 2022.